Cassava Sciences (SAVA)
(Delayed Data from NSDQ)
$26.21 USD
+0.41 (1.57%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $26.12 -0.09 (-0.34%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.21 USD
+0.41 (1.57%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $26.12 -0.09 (-0.34%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Zacks News
Cassava Sciences (SAVA) Jumps: Stock Rises 9.2%
by Zacks Equity Research
Cassava Sciences (SAVA) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Cassava Sciences (SAVA) in Focus: Stock Moves 8.5% Higher
by Zacks Equity Research
Cassava Sciences (SAVA) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Add Value to Your Portfolio With 5 High Earnings Yield Picks
by Rimmi Singhi
If other factors are constant while comparing stocks, the one with a higher earnings yield has the potential to provide comparatively greater returns.
Company News for Apr 24, 2020
by Zacks Equity Research
Companies In The News Are: LLY, SAVA, FLR, LYTS
What Lies Ahead for Cassava Sciences (SAVA) in Q4 Earnings?
by Zacks Equity Research
During the Q4 investors' call, Cassava Sciences (SAVA) is likely to provide an update on its lead candidate PT-125, which is being developed for the treatment of Alzheimer's disease.
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
Buy Multibagger Stocks as Odds of a Rally Are High in 2020
by Tirthankar Chakraborty
Multibagger stocks can make most of the bull run, courtesy of strong fundamentals and businesses that can multiply in a short span of time.
Zacks.com featured highlights include: Cassava Sciences, Rubicon Project, Talos Energy, Teekay Tankers and Karyopharm Therapeutics
by Zacks Equity Research
Zacks.com featured highlights include: Cassava Sciences, Rubicon Project, Talos Energy, Teekay Tankers and Karyopharm Therapeutics
5 Stocks With Recent Price Strength for Spectacular Returns
by Nalak Das
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Company News For Jan 3, 2020
by Zacks Equity Research
Companies in the news are: CMG, SAVA, RCON, IPHA
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
5 Stocks to Soar in 2020 After Solid Gains in 2019
by Zacks Equity Research
U.S. stocks rallied to attained fresh all-time highs in 2019, as the momentum continued in 2020. Here are five stocks that are poised to grow.
Biotech Rally Sends Nasdaq to 9000: ETFs in Focus
by Sanghamitra Saha
Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.
Top Ranked Momentum Stocks to Buy for December 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 10th
Top Ranked Momentum Stocks to Buy for December 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, December 4th
6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day
by Kinjel Shah
Here we discuss six small-cap companies with promising candidates in their pipeline for Alzheimer's disease.